What an incredible few days at Jefferies & London Life Science Week! 🎉 A huge thank you to Jefferies, the BioIndustry Association (BIA), MedCity, and London & Partners for hosting this goliath event. It gets bigger, better and more impactful every year, and we’re proud to be part of it. We are glad so many […]
Last week, Optimum hosted its 17th Annual Healthcare Investor Conference 2025. Held in the heart of London, the event brought together a powerhouse of industry leaders, investors, innovators, and communicators to exchange ideas, explore the market outlook, and tackle the pressing questions facing the life sciences sector. If you missed the day, or just want […]
18 new portfolio investments Five portfolio companies acquired $766 million invested and committed $600 million of cash exit proceeds San Francisco, Boston, London, and Copenhagen, Denmark, 5 March 2024 – The Novo Holdings Venture Investments team today published its review of 2023 – a record year advancing innovative therapies for patients. Read more…
The Novo Holdings Venture Investments team has published its 2023 newsletter today.  It is one of the largest and most active international life science venture investors with a track record of over 20 years investing in novel therapies.   For more information, please see Venture Investments 2023 Newsletter.  Â
Over US$ 550 million raised by portfolio companies in 2021 IO Biotech IPO on US NASDAQ Forendo Pharma acquired for nearly US$ 1 billion Muna launched with world-leading science to advance latest scientific breakthroughs in neuroscience Adcendo raised US$ 60 million Series A to deliver next-generation Antibody-Drug Conjugates Hemab raised US$ 50 million Series A to […]
